Microbot Medical Inc. (MBOT)
1.71
-0.03 (-1.72%)
At close: Feb 20, 2025, 3:59 PM
1.69
-0.88%
After-hours: Feb 20, 2025, 06:24 PM EST
undefined% (undefined)
| Bid | 1.68 |
| Market Cap | 59.24M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.79 |
| PE Ratio (ttm) | -2.16 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 1.79 |
| Volume | 1,841,258 |
| Avg. Volume (20D) | 3,926,242 |
| Open | 1.70 |
| Previous Close | 1.74 |
| Day's Range | 1.64 - 1.75 |
| 52-Week Range | 0.82 - 3.38 |
| Beta | undefined |
About MBOT
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional ...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Mar 25, 1992
Employees 21
Stock Exchange NASDAQ
Ticker Symbol MBOT
Website https://www.microbotmedical.com
Analyst Forecast
According to 1 analyst ratings, the average rating for MBOT stock is "Strong Buy." The 12-month stock price forecast is $9, which is an increase of 427.86% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
1 week ago
-9.41%
Microbot Medical shares are trading lower after th...
Unlock content with
Pro Subscription
2 weeks ago
+13.81%
Microbot Medical shares are trading higher after the company announced it will present its LIBERTY endovascular system data at the Society of Interventional Radiology meeting in March of 2025.
